Literature DB >> 6316440

Beta 2-adrenoceptor density on membranes and on intact mononuclear cells in essential hypertension.

M Middeke, J Remien, L H Block, S Kirzinger, A Landrock, H Holzgreve.   

Abstract

Alterations in the status or in the regulation of adrenoceptors may contribute to essential hypertension. This could be studied using the recently introduced radio-ligand binding techniques to characterize the adrenoceptors on human peripheral blood cells. The present study shows that patients with essential hypertension have a twofold increase of beta 2-adrenoceptor density on intact mononuclear cells as compared to normotensive controls: 859 +/- 260 (n = 10) vs. 420 +/- 119 (n = 10) maximal binding sites for (+/-) 125-Iodocyanopindolol expressed as molecules per cell (P less than 0.001). Furthermore, there is a highly significant correlation (r = 0.86) between the calculated mean arterial blood pressure and the beta 2-adrenoceptor density over a wide range of normal and increased blood pressure. These findings could only be demonstrated with intact mononuclear cells but not with membrane fractions. No difference was found in receptor affinity between patients with essential hypertension and normotensive controls. Thus, essential hypertension is combined with a higher beta 2-adrenoceptor density on intact mononuclear cells which might represent, for example, an increased density of prejunctional beta 2-adrenoceptors. Mean arterial blood pressure is positively correlated with beta 2-adrenoceptor density over a wide range of blood pressure in normotensives and hypertensives. The expression of beta 2-binding sites on the cell surface is possibly altered in essential hypertension resulting in a disparity between intracellular and extracellular binding sites as compared with normotensives.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316440     DOI: 10.1007/bf01855645

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  6 in total

1.  [Adrenergic receptors and hypertension in pregnancy].

Authors:  M Middeke
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Beta-adrenergic blood pressure regulation in Shy-Drager syndrome and pheochromocytoma.

Authors:  M Middeke; J Ittner; M Mezger; S Reder; J Remien
Journal:  Klin Wochenschr       Date:  1989-10-02

3.  Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease.

Authors:  Suzi Hong; Stoyan Dimitrov; Tiefu Cheng; Laura Redwine; Christopher Pruitt; Paul J Mills; Michael G Ziegler; J Michael Green; Farah Shaikh; Kathleen Wilson
Journal:  Brain Behav Immun       Date:  2015-08-20       Impact factor: 7.217

4.  Circannual variation in the expression of beta 2-adrenoceptors on human peripheral mononuclear leukocytes (MNLs).

Authors:  E Haen; I Langenmayer; A Pangerl; B Liebl; J Remien
Journal:  Klin Wochenschr       Date:  1988-07-01

5.  Acute regulation of lymphocyte beta-adrenoceptor activity in pheochromocytoma.

Authors:  M Middeke; G Lohmöller; J Remien; S Kirzinger; H Holzgreve
Journal:  Klin Wochenschr       Date:  1988-03-01

6.  Tyrosine hydroxylase and β2-adrenergic receptor expression in leukocytes of spontaneously hypertensive rats: putative peripheral markers of central sympathetic activity.

Authors:  L M Nisimura; P Bousquet; F Muccillo; E Tibirica; L R Garzoni
Journal:  Braz J Med Biol Res       Date:  2020-10-30       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.